ZAVENTEM, Belgium — In 1992, the Inovoject® device launched by Embrex® was a major advance in poultry health, ending the devastating impact of Marek’s disease on poultry flocks in the United States. Since then, the groundbreaking technology has continued to develop and expand to cover other common poultry diseases complementing the continuum of care for poultry in preventing diseases thanks to automated vaccination, the company noted.
“Embrex BioDevices® are now used to inject more than 20 billion eggs every year in 30 countries around the world. And we are incredibly proud of the positive impact it has had since it. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
